What is Renalogic?
Founded in 2002, Renalogic has established itself as the industry leader in dialysis cost containment. The company operates at the intersection of clinical intervention and financial efficiency, utilizing advanced data modeling to identify the progression of kidney disease before it reaches the end stage. By simplifying the clinical complexities of chronic conditions, Renalogic provides a unique value proposition to self-funded employers and health plans, effectively reducing the incidence rate of dialysis through early detection and proactive management. Their market position is defined by a commitment to preventing the transition to End Stage Renal Disease, a strategy that yields substantial savings for healthcare payers while improving the quality of life for covered populations.
How much funding has Renalogic raised?
Renalogic has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Renalogic
PPP
Public-Private Partnership
What's next for Renalogic?
With the support of its recent capital injection, Renalogic is well-positioned to accelerate its technological roadmap and expand its footprint in the enterprise healthcare market. The company's strategic focus remains on enhancing its predictive analytics engine, which is central to its ability to identify at-risk patients early. As the healthcare industry shifts toward value-based care models, Renalogic's ability to demonstrate measurable cost avoidance will likely become an even more critical asset for its clients. Future growth initiatives will likely involve scaling the reach of its Kidney Dialysis Avoidance Program to a broader demographic, further cementing its status as an essential partner for organizations seeking to manage the rising costs of chronic disease management.
See full Renalogic company page
